Systemic Lupus Erythematosus (SLE)

Systemic Lupus Erythematosus - The Hong Kong Society of Rheumatology

Member List

Chairperson
  • Dr. CC Mok Chi Chiu
Members
  • Dr. Ho Tze Kwan Carmen
  • Dr. Leung Moon Ho
  • Dr. To Chi Hung
  • Dr. Catherine Yuen
  • Dr. Wong Pui Yan Stella
  • Dr. Ciang Chu Oi, Natalia

Previous Events

Workshop on Systemic Lupus Erythematosus (10 Mar 2018) The workshop was organized by the Hong Kong Society of Rheumatology SLE Special Interest group. The targeted audience was rheumatology trainees, nurses and specialists. This well attended workshop covered various topics as below: -ASSESSMENT OF DISEASE ACTIVITY OF SLE by Dr Natalia Chu Oi Ciang from Hong Kong -ROLE OF THE CALCINEURIN INHIBITORS IN THE TREATMENT OF SLE by Dr Chi Chiu Mok from Hong Kong -QUEST FOR NOVEL BIOMARKERS IN SLE by Professor Chandra Mohan from the University of Houston in the USA. The workshop was embellished with discussion of management of difficult lupus cases by Dr Chi Chiu Mok & Dr Moon Ho Leung.

Workshop on Systemic Lupus Erythematosus (10 Mar 2018) The workshop was organized by the Hong Kong Society of Rheumatology SLE Special Interest group. The targeted audience was rheumatology trainees, nurses and specialists. This well attended workshop covered various topics as below: -ASSESSMENT OF DISEASE ACTIVITY OF SLE by Dr Natalia Chu Oi Ciang from Hong Kong -ROLE OF THE CALCINEURIN INHIBITORS IN THE TREATMENT OF SLE by Dr Chi Chiu Mok from Hong Kong -QUEST FOR NOVEL BIOMARKERS IN SLE by Professor Chandra Mohan from the University of Houston in the USA. The workshop was embellished with discussion of management of difficult lupus cases by Dr Chi Chiu Mok & Dr Moon Ho Leung.

Workshop on Systemic Lupus Erythematosus (10 Mar 2018) The workshop was organized by the Hong Kong Society of Rheumatology SLE Special Interest group. The targeted audience was rheumatology trainees, nurses and specialists. This well attended workshop covered various topics as below: -ASSESSMENT OF DISEASE ACTIVITY OF SLE by Dr Natalia Chu Oi Ciang from Hong Kong -ROLE OF THE CALCINEURIN INHIBITORS IN THE TREATMENT OF SLE by Dr Chi Chiu Mok from Hong Kong -QUEST FOR NOVEL BIOMARKERS IN SLE by Professor Chandra Mohan from the University of Houston in the USA. The workshop was embellished with discussion of management of difficult lupus cases by Dr Chi Chiu Mok & Dr Moon Ho Leung.

Workshop on Systemic Lupus Erythematosus (10 Mar 2018) The workshop was organized by the Hong Kong Society of Rheumatology SLE Special Interest group. The targeted audience was rheumatology trainees, nurses and specialists. This well attended workshop covered various topics as below: -ASSESSMENT OF DISEASE ACTIVITY OF SLE by Dr Natalia Chu Oi Ciang from Hong Kong -ROLE OF THE CALCINEURIN INHIBITORS IN THE TREATMENT OF SLE by Dr Chi Chiu Mok from Hong Kong -QUEST FOR NOVEL BIOMARKERS IN SLE by Professor Chandra Mohan from the University of Houston in the USA. The workshop was embellished with discussion of management of difficult lupus cases by Dr Chi Chiu Mok & Dr Moon Ho Leung.

Workshop on Systemic Lupus Erythematosus (10 Mar 2018) The workshop was organized by the Hong Kong Society of Rheumatology SLE Special Interest group. The targeted audience was rheumatology trainees, nurses and specialists. This well attended workshop covered various topics as below: -ASSESSMENT OF DISEASE ACTIVITY OF SLE by Dr Natalia Chu Oi Ciang from Hong Kong -ROLE OF THE CALCINEURIN INHIBITORS IN THE TREATMENT OF SLE by Dr Chi Chiu Mok from Hong Kong -QUEST FOR NOVEL BIOMARKERS IN SLE by Professor Chandra Mohan from the University of Houston in the USA. The workshop was embellished with discussion of management of difficult lupus cases by Dr Chi Chiu Mok & Dr Moon Ho Leung.

Biologics' Role in Achieving Early and Sustained Remission: Real-World Insights from Lupus Case Discussion Forum


On 26 April 2025, approximately 20 healthcare professionals gathered for the Hong Kong Lupus Case Discussion Forum, moderated by Prof. CC Mok and Prof. KL Lee. The event featured esteemed speakers who shared invaluable insights into optimizing SLE management and their clinical experiences. Prof. Luís Inês highlighted the importance of achieving early and sustained remission to prevent organ damage and shared the recent advancements in SLE disease activity indices. Prof. Chen Ming-Han discussed the biologics experience with SLE patients, offering crucial insights into steroid-sparing strategies within the real-world Taiwan setting.


Additionally, the forum featured engaging case studies presented by the two speakers and Prof. Shirley Chan. These discussions facilitated in-depth interactions between Hong Kong and experts from Taiwan and Portugal. This cross-regional dialogue served as a valuable platform for sharing knowledge and improving strategies in SLE care across diverse healthcare settings.